Miller CT - Search Results

1

Increased C-CRK proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas.

Miller CT, Chen G, Gharib TG, Wang H, Thomas DG, Misek DE, Giordano TJ, Yee J, Orringer MB, Hanash SM, Beer DG. Miller CT, et al. Oncogene. 2003 Sep 11;22(39):7950-7. doi: 10.1038/sj.onc.1206529. Oncogene. 2003. PMID: 12970743

2

Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma.

Miller CT, Lin L, Casper AM, Lim J, Thomas DG, Orringer MB, Chang AC, Chambers AF, Giordano TJ, Glover TW, Beer DG. Miller CT, et al. Oncogene. 2006 Jan 19;25(3):409-18. doi: 10.1038/sj.onc.1209057. Oncogene. 2006. PMID: 16186806

3

The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas.

Lin L, Miller CT, Contreras JI, Prescott MS, Dagenais SL, Wu R, Yee J, Orringer MB, Misek DE, Hanash SM, Glover TW, Beer DG. Lin L, et al. Among authors: miller ct. Cancer Res. 2002 Sep 15;62(18):5273-9. Cancer Res. 2002. PMID: 12234996

4

Amplification and overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung adenocarcinomas.

Miller CT, Aggarwal S, Lin TK, Dagenais SL, Contreras JI, Orringer MB, Glover TW, Beer DG, Lin L. Miller CT, et al. Cancer Res. 2003 Jul 15;63(14):4136-43. Cancer Res. 2003. PMID: 12874018

5

Reduced selenium-binding protein 1 expression is associated with poor outcome in lung adenocarcinomas.

Chen G, Wang H, Miller CT, Thomas DG, Gharib TG, Misek DE, Giordano TJ, Orringer MB, Hanash SM, Beer DG. Chen G, et al. Among authors: miller ct. J Pathol. 2004 Mar;202(3):321-9. doi: 10.1002/path.1524. J Pathol. 2004. PMID: 14991897 Free article.

6

Gene amplification in esophageal adenocarcinomas and Barrett's with high-grade dysplasia.

Miller CT, Moy JR, Lin L, Schipper M, Normolle D, Brenner DE, Iannettoni MD, Orringer MB, Beer DG. Miller CT, et al. Clin Cancer Res. 2003 Oct 15;9(13):4819-25. Clin Cancer Res. 2003. PMID: 14581353

7

Cdc7p-Dbf4p regulates mitotic exit by inhibiting Polo kinase.

Miller CT, Gabrielse C, Chen YC, Weinreich M. Miller CT, et al. PLoS Genet. 2009 May;5(5):e1000498. doi: 10.1371/journal.pgen.1000498. Epub 2009 May 29. PLoS Genet. 2009. PMID: 19478884 Free PMC article.

8

Are some people more susceptible to placebos? A systematic review and meta-analysis of inter-individual variability in musculoskeletal pain.

Saueressig T, Owen PJ, Pedder H, Kaczorowski S, Miller CT, Donath L, Belavý DL. Saueressig T, et al. Among authors: miller ct. J Pain. 2024 Nov 28:104745. doi: 10.1016/j.jpain.2024.104745. Online ahead of print. J Pain. 2024. PMID: 39613126 Review.

9

The BRAIN initiative: a pioneering program on the precipice.

Miller CT, Chen X, Donaldson ZR, Marlin BJ, Tsao DY, Williams ZM, Zelikowsky M, Zeng H, Hong W. Miller CT, et al. Nat Neurosci. 2024 Dec;27(12):2264-2266. doi: 10.1038/s41593-024-01811-3. Nat Neurosci. 2024. PMID: 39578571 No abstract available.

10

Running is acceptable and efficacious in adults with non-specific chronic low back pain: the ASTEROID randomised controlled trial.

Neason C, Samanna CL, Tagliaferri SD, Belavý DL, Bowe SJ, Clarkson MJ, Craige EA, Gollan R, Main LC, Miller CT, Mitchell UH, Mundell NL, Scott D, Tait JL, Vincent GE, Owen PJ. Neason C, et al. Among authors: miller ct. Br J Sports Med. 2025 Jan 2;59(2):99-108. doi: 10.1136/bjsports-2024-108245. Br J Sports Med. 2025. PMID: 39375007 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

256 results

Search Page

Filters